Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the Drug [0.03%]
熊去氧胆酸治疗与代谢功能障碍相关脂肪性肝病：现有证据足以支持临床使用吗？对一项III期试验及其药物监管许可的评论
Karan Kumar,Vivek Saraswat,Ashish Kumar et al.
Karan Kumar et al.
Self-Reported Cognitive Function in Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Post-hoc Analysis of the MAESTRO Resmetirom Trials [0.03%]
代谢紊乱相关肝病患者中的认知功能：来自MAESTRO瑞美司他试验的事后分析研究
Zobair M Younossi,Fatema Nader,Dominic Labriola et al.
Zobair M Younossi et al.
Background: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) may experience cognitive impairment that negatively impacts their health-related quality of life (HRQL). ...
Post Hoc Analysis of a Phase 2 Randomized Trial of Pemafibrate in Metabolic Dysfunction-associated Steatotic Liver Disease: Associations With Platelet Count, Liver Stiffness, and Spleen Volume [0.03%]
匹马普利贝治疗与代谢功能障碍相关脂肪肝病2期随机试验的事后分析：血小板计数、肝脏硬度和脾体积的关联性研究
Ryohei Tanigawa,Rohit Loomba,Yuichiro Eguchi et al.
Ryohei Tanigawa et al.
Background/aims: Portal hypertension is a major complication in metabolic dysfunction-associated steatotic liver disease (MASLD). In the PEMA-FL (PEMAfibrate randomised placebo-controlled study in patients with non-alcoho...
Establishing Region-specific Testing Strategies for Minimal Hepatic Encephalopathy: Lessons and Future Perspectives from a Young, Literate Indian Cohort [0.03%]
建立地区特定的轻度肝性脑病检测策略：来自年轻、识字的印度队列的经验和未来展望
Takao Miwa,Masahito Shimizu,Bernd Schnabl
Takao Miwa
Septic Shock Management in Cirrhosis: Beyond "One-Size-Fits-All" Resuscitation With POCUS-Guided Precision [0.03%]
肝硬化患者的脓毒性休克治疗：“量身定制”治疗优于“一刀切”复苏POCUS引导精准治疗
Nagasri Shankar,Kavish R Patidar
Nagasri Shankar
Phenotype-specific Inflammatory Signatures in Steatotic Liver Disease: Implications for Precision Medicine in Hepatology [0.03%]
肝脂肪变性疾病的表型特异性炎症标志物：精准医疗的启示
Kriti Soni,Juan P Arab,Luis A Díaz
Kriti Soni
Pankaj Puri
Pankaj Puri
The Cortex in Context: Making Sense of Hepatic Encephalopathy as a Prognostic Factor in Cirrhosis-Related Hospitalization [0.03%]
背景下的皮质：肝性脑病作为肝硬化相关住院的预后因素的意义探究
Adam Buckholz,Elliot B Tapper
Adam Buckholz
Therapies for Prevention of Gastric Variceal Bleeding: Do We Have a Winner? [0.03%]
预防胃静脉曲张出血的治疗：谁是赢家？
Sanchit Sharma,Dhiraj Tripathi
Sanchit Sharma